BlackRock Inc. increased its stake in shares of Adaptive Biotechnologies by 9.1% in the 1st quarter.

Source: https://www.etfdailynews.com/2023/01/05/clarius-group-llc-acquires-3610-shares-of-adaptive-biotechnologies-co-nasdaqadpt/

BNP Paribas Arbitrage SA boosted its stake in shares of Adverum Biotechnologies by 426.8% during the 2nd quarter.

Source: https://www.etfdailynews.com/2023/07/20/adverum-biotechnologies-inc-nasdaqadvm-short-interest-down-14-1-in-june/

Federated Hermes Inc. increased its holdings in shares of Adaptive Biotechnologies by 151.3% in the 2nd quarter.

Source: https://www.etfdailynews.com/2023/02/26/adaptive-biotechnologies-co-nasdaqadpt-shares-acquired-by-pictet-asset-management-sa/

Morgan Stanley decreased their target price on shares of Adaptive Biotechnologies from $14.00 to $13.00 and set an “equal weight” rating on the stock in a research report on Friday, August 4th.

Source: https://www.etfdailynews.com/2023/10/05/adaptive-biotechnologies-nasdaqadpt-stock-price-down-5-8/

Receive News & Ratings for Adverum Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adverum Biotechnologies and related companies with MarketBeat.

Source: https://www.etfdailynews.com/2023/02/24/adverum-biotechnologies-inc-nasdaqadvm-shares-acquired-by-connor-clark-lunn-investment-management-ltd/

Receive News & Ratings for Adverum Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adverum Biotechnologies and related companies with MarketBeat.

Source: https://www.etfdailynews.com/2023/02/24/adverum-biotechnologies-inc-nasdaqadvm-shares-acquired-by-connor-clark-lunn-investment-management-ltd/